Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 13;15(22):5385.
doi: 10.3390/cancers15225385.

Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy

Affiliations

Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy

Shi-Ming Tu et al. Cancers (Basel). .

Abstract

A simple way to understand the immune system is to separate the self from non-self. If it is self, the immune system tolerates and spares. If it is non-self, the immune system attacks and destroys. Consequently, if cancer has a stem cell origin and is a stem cell disease, we have a serious problem and a major dilemma with immunotherapy. Because many refractory cancers are more self than non-self, immunotherapy may become an uphill battle and pyrrhic victory in cancer care. In this article, we elucidate cancer immunity. We demonstrate for whom, with what, as well as when and how to apply immunotherapy in cancer care. We illustrate that a stem cell theory of cancer affects our perspectives and narratives of cancer. Without a pertinent theory about cancer's origin and nature, we may unwittingly perform misdirected cancer research and prescribe misguided cancer treatments. In the ongoing saga of immunotherapy, we are at a critical juncture. Because of the allure and promises of immunotherapy, we will be treating more patients not immediately threatened by their cancer. They may have more to lose than to gain, if we have a misconception and if we are on a wrong mission with immunotherapy. According to the stem cell theory of cancer, we should be careful with immunotherapy. When we do not know or realize that cancer originates from a stem cell and has stem-ness capabilities, we may cause more harm than good in some patients and fail to separate the truth from the myth about immunotherapy in cancer care.

Keywords: autoimmunity; cancer stem cell; cancer vaccine; heterogeneity; hyper-progression; immunotherapy; microbiome; microenvironment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Myth of Lucifer, the fallen angel. Cancer stem cells mirror, if not mimic, normal stem cells. Reproduced with permission from Benjamin Tu (www.bentubox.com, accessed on 10 September 2023).

Similar articles

Cited by

References

    1. Vezzoni L., Parmiani G. Limitations of the cancer stem cell theory. Cytotechnology. 2008;58:3–9. doi: 10.1007/s10616-008-9166-8. - DOI - PMC - PubMed
    1. Bartram I., Jeschke J.M. Do cancer stem cells exist? A pilot study combining a systematic review with the hierarchy-of-hypotheses approach. PLoS ONE. 2019;14:e0225898. doi: 10.1371/journal.pone.0225898. - DOI - PMC - PubMed
    1. Kaushik V., Kulkarni Y., Felix K., Azad N., Iyer A.K.V., Yakisich J.S. Alternative models of cancer stem cells: The Stemness phenotype model, 10 years later. World J. Stem Cells. 2021;13:934–943. doi: 10.4252/wjsc.v13.i7.934. - DOI - PMC - PubMed
    1. Vessoni A.T., Filippi-Chiela E.C., Lenz G., Zirnberger Batista L.F. Tumor propagating cells: Drivers of tumor plasticity, heterogeneity, and recurrence. Oncogene. 2020;39:2055–2068. doi: 10.1038/s41388-019-1128-4. - DOI - PubMed
    1. Tu S.M. In: Origin of Cancers. Clinical Perspectives and Implications of a Stem-Cell Theory of Cancer. Rosen S.T., editor. Volume 154 Springer; New York, NY, USA: 2010. Cancer Treatment and Research. - PubMed

Grants and funding

This research received no external funding.

LinkOut - more resources